Nobel Prize Excellence: 7 Powerful Lessons for ISO 7101

Excellence. Evidence. Endurance.

By Diana Lynn, President and Principal ISO Consultant, MSI · Updated October 7, 2026

Nobel Prize excellence is the rare combination of original discovery, proven benefit to humankind, and evidence strong enough to survive decades of scrutiny. At 12:27 a.m. Pacific time on October 5, 2026, a Stanford professor who was drifting off to sleep answered his phone and learned that his life’s work had cleared that bar. His name is Karl Deisseroth. He is a bioengineer and a practicing psychiatrist, and the work that earned him the call began with a protein found in pond algae.

I have always been intrigued by Nobel laureates. To me they are the purest example of excellence the world has agreed on. No one buys their way onto that list, no one nominates themselves, and no one wins on a single good year. In 28 years of ISO consulting, I have learned that the organizations that achieve lasting quality share the same traits that define Nobel Prize excellence. This article explains what it takes to be nominated, what the 2026 Medicine prize rewarded, how Professor Deisseroth explains optogenetics, and why his discovery brings real hope to every healthcare quality management system (HCQMS) built on ISO 7101.

What Is Nobel Prize Excellence, and Why Should Quality Leaders Care?

Nobel Prize excellence is not brilliance alone. Plenty of brilliant people never receive the call. What separates laureates is a pattern: a precise question, a method others can repeat, results that hold up when strangers test them, and a benefit that reaches people outside the laboratory. Alfred Nobel’s will asked that the prizes go to those who conferred the greatest benefit on humankind, and the committees still read that phrase literally.

Quality leaders should care because that pattern is exactly what a management system is designed to produce. A procedure that works in practice, a corrective action that eliminates a cause, and an indicator that tells the truth are all small acts of the same discipline. The difference between a good organization and an excellent one is usually not talent. It is whether the organization has systems that make excellent work repeatable, the same foundation that sits beneath Nobel Prize excellence.

When we talk about Nobel Prize excellence in healthcare, the stakes become personal. Every clause in ISO 7101 eventually touches a patient, a family or a caregiver. That is why the 2026 Medicine prize is worth studying closely, not just celebrating. If you want to see how other laureates have modeled leadership, our article on women Nobel laureates and business leadership excellence is a good companion read.

How Is Nobel Prize Excellence Nominated? The Invitation-Only Process

The nomination process is one of the most rigorous peer-review systems in the world. According to the official Nobel Prize nomination guidance for Physiology or Medicine, more than 3,000 invitations go out every September. They reach members of the Nobel Assembly and the Royal Swedish Academy of Sciences, past laureates in medicine and chemistry, full professors of medicine in the Nordic countries, professors at selected medical faculties around the world, and other scientists the Assembly chooses to approach.

Who Decides?

A Nobel Committee of five members plus a Secretary screens the nominations, commissions expert reviews and narrows the field. The 50 members of the Nobel Assembly at Karolinska Institutet then vote. The names of nominees, and every other detail of the nomination and selection, are restricted for 50 years. That secrecy matters. It means no one can campaign their way onto the shortlist, and Nobel Prize excellence rests entirely on evidence.

What Nominators Look For

Nominators are asked to identify a discovery, not a career. The question is simple and unforgiving: did this specific finding change what the field knows or can do? That is why prizes often arrive decades after the original work. The committee waits until the evidence is overwhelming.

The 2026 laureates published their foundational papers between 2002 and 2005. The prize arrived more than 20 years later, after thousands of laboratories had confirmed, extended and applied the method.

The Management System Parallel

Certification under a management system standard works on a similar principle. An organization cannot certify itself into excellence. Independent auditors examine records, interview the workforce and test whether the system produces the results it claims. ISO 7101 itself lists four ways to demonstrate conformity in its introduction, ranging from self-declaration to certification by an external organization. The most credible path to Nobel Prize excellence, or to certified quality, is the one where someone independent examines the evidence.

In our ISO consulting work, we see the same lesson play out again and again. Organizations that build their quality system to satisfy a calendar date rarely sustain it. Organizations that build it to produce evidence, the way a laureate builds a body of work, find that certification becomes the natural result rather than the goal. You can learn more about how MSI approaches that kind of system on our ISO consulting services page.

What Did the 2026 Nobel Prize in Physiology or Medicine Reward?

As of October 7, 2026, the facts are well documented. Nature reported that the prize went to Deisseroth of Stanford University, Hegemann of Humboldt University of Berlin and Nagel of the University of Würzburg, with the 12 million kronor (about US$1.2 million) divided equally among the three. The official citation, listed on the Nobel Prize in Physiology or Medicine page, honors their discoveries concerning light-gated ion channels and optogenetics.

Act One: The Algae That Swim Toward Light

Nobel Prize excellence often begins with curiosity, not a business case. In the early 1990s, Hegemann and Nagel were studying a single-celled green alga called Chlamydomonas and asking a basic question: how does it know which way to swim toward light? STAT News reported that their work identified channelrhodopsin, a protein channel that opens almost instantly when light hits it, letting charged particles flow into the cell. Crucially, it worked in other cells too.

Act Two: From Algae to the Living Brain

Deisseroth started his own laboratory at Stanford in 2004. He ran the first experiment with channelrhodopsin himself, in July of that year. His team introduced the gene into rat nerve cells, and blue light made those cells fire. The landmark paper appeared in Nature Neuroscience in 2005, with his then-graduate student Ed Boyden as first author. Within about two years, according to the Howard Hughes Medical Institute, the technique was working in living mice.

Act Three: A Tool the Whole World Uses

Today optogenetics is used in laboratories worldwide, in animals ranging from mice and fish to roundworms and mosquitoes. GEN and C&EN both describe it as one of the defining research methods of modern neuroscience. Nature’s coverage notes that it has deepened understanding of depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease. That is what Nobel Prize excellence looks like at scale: a discovery that becomes the platform for thousands of other discoveries.

How Does the Stanford Professor Explain Optogenetics?

In Stanford Medicine’s announcement, Deisseroth describes the key principle of optogenetics as “precise causal perturbation.” Put simply, you cannot fully understand a system by watching it. You have to change one part of it, precisely, and see what happens.

Why Older Tools Fell Short

Before optogenetics, scientists had two main ways to influence the brain. Electrical stimulation could excite cells, but the current spread to neighboring circuits and could not precisely silence a neuron. Drugs could quiet cells, but they spread widely through the tissue and took a long time to switch off. Neither tool could answer the question every scientist cares about: which specific cells cause this specific behavior?

The Light Switch

Optogenetics solved that. Researchers deliver the gene for a light-sensitive microbial protein, called an opsin, into only the cell type they want to study. Blue light can then switch those cells on, and other opsins respond to yellow light by switching cells off.

Deisseroth’s team also developed fiber-optic methods to carry light deep into the brains of living animals, an effort his postdoctoral advisor, Rob Malenka, described as requiring enormous perseverance. Because the control works in milliseconds, scientists can now test cause and effect while an animal is actually behaving. That millisecond precision is a hallmark of Nobel Prize excellence.

A Psychiatrist at the Bench

What makes Deisseroth’s explanation so compelling for healthcare is his vantage point. He still practices psychiatry and sees patients with treatment-resistant depression and autism spectrum disorders. His group has used optogenetics to produce and relieve depression-like symptoms in mice, and, working with UCSF colleagues, to identify circuits involved in Parkinson’s disease. In 2023 he founded Stanford’s Human Neural Circuitry program, which brings psychiatrists, neurologists, neurosurgeons, anesthesiologists and bioengineers together to study the human brain directly. His stated hope is to understand brain function well enough to treat conditions from Parkinson’s to anxiety.

That is the Stanford professor’s real lesson for quality leaders. Observation tells you what is happening. Precise, controlled intervention tells you why. ISO 7101 asks healthcare organizations to make the same leap: to move from collecting data to determining causes, then acting on them.

Seven Powerful Lessons of Nobel Prize Excellence for ISO 7101

The story of optogenetics reveals seven traits of Nobel Prize excellence that any healthcare organization can build. Each lesson below links a habit of the laureates to a specific requirement of ISO 7101:2023, the first international standard written specifically for management systems for quality in healthcare organizations.

1. Start With a Precise Question

Hegemann and Nagel did not set out to revolutionize neuroscience. They asked how an alga finds light. Precision in the question produced precision in the answer, the first marker of Nobel Prize excellence.

In a healthcare quality management system, the equivalent is a well-defined quality objective. Clause 6.2 requires healthcare quality objectives to be measurable where practicable, monitored, and to use evidence-informed practice data and established indicators of health outcomes. Vague objectives produce vague results. Our guide to setting ISO 7101 healthcare quality objectives shows how to make them precise.

2. Prove Cause, Not Correlation

Precise causal perturbation is the scientific version of root cause analysis. Clause 10.2.2 requires organizations, when a nonconformity occurs, to determine its causes and whether similar nonconformities exist or could occur. It even lists fail-proofing among the actions to consider. A hospital that only counts falls is observing. A hospital that tests one change at a time and measures the effect is practicing Nobel Prize excellence at the unit level.

3. Let Evidence Overrule Opinion

The Nobel Assembly does not vote on charisma. It votes on evidence of Nobel Prize excellence.

ISO 7101 sets the same bar. Clause 9.1.3 requires that monitoring data be collected from reliable sources and based on statistical and scientific criteria. Clause 8.7 f) requires service design to consider the best available medical knowledge and scientific evidence. Organizations that adopt this mindset make better decisions everywhere, which is the theme of our article on evidence-based decision making.

4. Persist Through the Long Middle

Twenty-two years passed between Deisseroth’s first experiment and his Nobel call. In between came failed attempts, technical obstacles and the slow work of getting light into a living brain.

ISO 7101 builds persistence into its design. Its introduction describes the Plan-Do-Study-Act model as an iterative process of ongoing measurement and assessment of changes, and Clause 10.1 requires organizations to continually improve the suitability, adequacy and effectiveness of the system. Continual improvement is simply persistence written as a requirement, and persistence is the quiet engine of Nobel Prize excellence. Our article on continual improvement explains how to keep that cycle moving.

5. Share What Works So Others Can Repeat It

One reason optogenetics spread so quickly is that Deisseroth shared it. Colleagues describe how his lab distributed its engineered genes, reagents and protocols widely and trained thousands of scientists. Nobel Prize excellence multiplies when it is shared.

ISO 7101 Clause 6.3 b) asks organizations planning changes to consider replicating best practices and building the infrastructure to support full-scale implementation beyond project mode. Clause 8.12.2 b) requires a process for sharing lessons learned in patient safety. A great practice that lives in one unit is a pilot. A great practice that every unit can repeat is a system.

6. Stay Close to the People You Serve

Deisseroth never left the clinic. His patients keep his research honest about what matters. Nobel Prize excellence in medicine stays anchored to the patient.

ISO 7101 makes the same demand of top management. Clause 5.4 requires leaders to listen and respond to the service user’s voice, assess service user experience and use those lessons to drive change. Clause 8.10 builds a full people-centred care framework around experience, compassion, health literacy and co-production. Read more in our articles on ISO 7101 patient-centered care and building a healthcare quality culture.

7. Lead With Ethics at the Frontier

Any technology powerful enough to switch brain cells on and off demands ethical discipline. The research community built that discipline into animal studies, consent and review long before human trials began. ISO 7101 Clause 8.11 requires defined processes for identifying, investigating, analysing and addressing ethical dilemmas, including human subject research, with workforce training and service user involvement in ethical decisions. Nobel Prize excellence without ethics is not excellence at all.

Why Optogenetics Brings Hope to the Healthcare Quality Management System

It is important to be honest about where the science stands. As of October 7, 2026, optogenetics remains primarily a research tool. It is not a routine hospital treatment. But the first signs of clinical promise are real, and they show why a strong healthcare quality management system matters more, not less, as medicine advances. Nobel Prize excellence in the laboratory only helps patients when the system receiving it is excellent too.

The Patient Who Saw Again

In May 2021, a team led by José-Alain Sahel and Botond Roska reported in Nature Medicine that a man blinded by retinitis pigmentosa, an inherited disease that destroys the retina’s light-sensing cells, had regained partial vision. According to Sorbonne Université, researchers used gene therapy to deliver a channelrhodopsin called ChrimsonR into his retinal ganglion cells. Wearing goggles that projected amber light onto his retina, he could locate, touch and count objects on a table. He touched a large notebook in 36 of 39 trials. It was one patient, and his vision was limited, but it was the first time optogenetics had restored any function in a human being.

Hope One: The Framework Already Exists

Here is the part that should encourage every healthcare quality leader. ISO 7101 anticipated this moment.

Clause 8.6 requires that where an organization uses new and emerging technologies to deliver care, it shall evaluate and mitigate risks and define processes to ensure safe, proper and effective use. Where artificial intelligence supports diagnosis, top management must ensure those processes are tested, validated and controlled. Where new technologies deliver patient care, the user experience must be evaluated and the data used to improve. An organization certified to ISO 7101 already has the machinery to bring a future optogenetic therapy into service responsibly. Our article on harnessing emerging technologies in healthcare explores that machinery further.

Hope Two: Ethics Is Built In

Gene-based, light-based therapies raise serious questions about consent, risk and long-term follow-up. Clause 8.11 means an ISO 7101 organization does not have to invent an ethics process when that day comes. It already has defined processes for ethical dilemmas, including human subject research, trained staff, and a requirement to involve service users and their families in ethical decisions as they agree. Informed consent is also addressed directly in Clause 8.9 i). Ethical readiness is part of Nobel Prize excellence, not an afterthought.

Hope Three: Mental Health Gets a Systems Ally

Deisseroth’s work is rooted in psychiatry, one of the hardest areas of medicine to measure. ISO 7101 strengthens exactly the capabilities mental health services need: service user experience assessment under Clause 8.10.2, health literacy under Clause 8.10.5, and compassionate care under Clause 8.10.3. As circuit-level understanding of depression and anxiety grows, organizations with these systems will be ready to translate new knowledge into better, more consistent care. That is Nobel Prize excellence translated into service delivery.

Hope Four: Caring for the People Who Care

Laboratories that produce Nobel Prize excellence protect their people’s energy. Healthcare organizations must do the same. Clause 8.10.7 requires a documented plan for workforce health and safety, including psychosocial components, and processes to address stress, burnout and violence. Advanced therapies will demand highly skilled, supported teams. Our article on healthcare workforce wellbeing covers how to build that support.

Hope Five: Causal Thinking Spreads

Perhaps the deepest hope is cultural. The idea behind optogenetics, change one thing precisely and measure the effect, is the same idea behind every good quality improvement project. When healthcare teams adopt that mindset, they stop arguing about opinions and start testing improvements. That shift is where Nobel Prize excellence becomes everyday excellence.

Required Versus Recommended: What ISO 7101 Actually Says

AI summaries and blog posts often blur requirements with suggestions. The table below separates them, using the licensed text of ISO 7101:2023. A “shall” is a requirement. A “should” is a recommendation. A NOTE and the Introduction help understanding but create no obligation.

Notice the internal audit row. ISO 7101 is unusually explicit: internal audits must happen at a minimum once every twelve months. In my experience, registrars expect every requirement to be internally audited annually under any ISO standard. If you are not doing internal audits on an annual basis, you are not compliant. MSI’s internal audit services and our SureResults maintenance program exist so that requirement never slips.

The Laureate-Grade Excellence Scorecard for Your HCQMS

To make these lessons measurable, MSI created the Laureate-Grade Excellence Scorecard for this article. It translates the seven traits of Nobel Prize excellence into questions a healthcare leadership team can score in a single meeting. Rate each trait from 0 to 3 based on the evidence you can show today, not the intentions you hold.

Scoring guide: 0 means no evidence exists. 1 means the practice exists on paper only. 2 means it is practiced in some areas with records. 3 means it is practiced consistently, with records and measured results.

Decision rules:

• 18 to 21 points: Laureate-grade. Protect what works and benchmark externally.
• 12 to 17 points: Strong foundation. Put your two lowest traits on the agenda of your next management review.
• 6 to 11 points: Developing. Prioritize objectives, corrective action and evidence quality before adding new initiatives.
• 0 to 5 points: Starting point. Schedule a planning session to map the system before investing further.

Organizations typically find that their lowest scores cluster around causal proof and shared practice. Those are the two traits most often skipped when teams are busy, and they are the two that separate good systems from Nobel Prize excellence.

Management Review: Your Organization’s Nomination File for Nobel Prize Excellence

A Nobel nominator cannot submit a feeling. They must document the discovery and its impact. Management review asks top management to do the same with the quality system. Clause 9.3.2 lists required inputs, including the status of previous actions, trends in nonconformities and corrective actions, audit results, service user experience, the extent to which quality objectives and health indicators have been met, patient safety, the performance of external providers, the adequacy of resources, accessibility of services, risk management and opportunities for improvement.

Two other clauses feed directly into that meeting. Clause 6.1.3 requires risk management results to be discussed during management review. Clause 8.10.2.2 requires the evaluation of user experience to be included in the required management review meeting. Clause 9.3.3 then requires the results to include decisions on improvement opportunities and any needed changes to the system.

At MSI, we recommend management review as the best way to start planning any major change. A quick way to begin is an “End in Mind” review: put the data you already have on the review slides, and mark anything missing as TBD with a date to close it. You will see immediately where your evidence is strong and where it is thin.

Management review is not unique to ISO 7101, either. It is required by ISO 9001, ISO 13485 and ISO 14001, including the ISO 9001:2026 edition published on September 16, 2026. Our articles on the benefits of management review and our ISO Management Review Toolkits give you a ready-made structure for every input.

Where ISO Consulting Turns Inspiration Into Results

Inspiration is the easy part. Building a system that produces Nobel Prize excellence every day takes structure, documentation and the discipline to keep improving. That is where experienced ISO consulting makes the difference between a binder on a shelf and a system that works in practice.

MSI has spent 28 years helping organizations across manufacturing, technology, medical device, government, healthcare and other regulated industries build management systems that deliver results. Our track record includes 80+ certifications supported, 200+ audits attended and 600+ professionals trained. We implement ISO 9001, ISO 13485, ISO 14001, ISO 45001 and ISO 7101, and that cross-standard experience lets us bring proven practices from one industry into another.

For healthcare organizations, ISO 7101 brings unique demands, from patient identification and medication safety to co-production and compassionate care. Our articles on ISO 7101 service design, ISO 7101 documentation and key steps for immediate action on ISO 7101 give leaders a practical starting point. When you are ready for a guided implementation, our SurePath implementation program carries you from planning to certification.

Integrity is the common thread in Nobel Prize excellence and in quality management. It runs from the Nobel Assembly’s 50-year seal of secrecy to a nurse documenting a near miss honestly at the end of a long shift. Both protect the truth so that good decisions can follow. You can read more about that connection in our article on ISO standards and integrity.

Your Next Step Toward Nobel Prize Excellence in Healthcare Quality

You do not need a laboratory in Stanford to practice Nobel Prize excellence. You need a precise question, reliable evidence, and a system that turns both into better care. Choose the path below that fits where your organization is today.

Frequently Asked Questions About Nobel Prize Excellence and ISO 7101

Can someone nominate themselves for a Nobel Prize?

Who won the 2026 Nobel Prize in Physiology or Medicine?

What is optogenetics in simple terms?

Is optogenetics used to treat patients today?

How does ISO 7101 prepare healthcare organizations for new therapies?

How can a healthcare organization measure its own Nobel Prize excellence?

References and Further Reading

• The Nobel Prize in Physiology or Medicine, NobelPrize.org
• Nomination and selection of Medicine laureates, NobelPrize.org
• Karl Deisseroth wins 2026 Nobel Prize, Stanford Medicine
• Reactions to a Nobel Prize win, Stanford Medicine
• Karl Deisseroth awarded the 2026 Nobel Prize, Howard Hughes Medical Institute
• Medicine Nobel awarded for brain switch that controls neurons with light, Nature
• 2026 Nobel Prize in Medicine awarded for optogenetics, STAT News
• 2026 Nobel Prize goes to optogenetics, GEN
• Optogenetics researchers win Nobel Prize, C&EN
• Optogenetic methods restore partial vision in a blind patient, Sorbonne Université
• ISO 7101:2023 Healthcare organization management, ISO
• WHO Quality Toolkit, World Health Organization (cited in the ISO 7101 bibliography)

Clause references are verified against the licensed text of ISO 7101:2023. News facts are current as of October 7, 2026. This article is for general information about management systems and is not medical advice.